| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_39c3a06706e79b48ef4d7b444ec7faaf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dfd617dc43a4c986d2dd81e4cb39d9dd |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-19 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-52 |
| filingDate |
1991-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea7e8b0213722c4c1b39faa59e8ca8b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b406eadf4ed5ebc5a2e5046fc1247e1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66a0feaccc26978ae6b7ad8a50ee8796
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0d494fabd3e06232d98f129c1f477a9 |
| publicationDate |
1993-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H0556794-A |
| titleOfInvention |
Method for producing bioactive peptide |
| abstract |
(57) [Summary] [Structure] A method for producing a physiologically active peptide having no aspartic acid-proline sequence by genetic recombination, comprising: Culturing cells transformed with an expression vector containing a gene encoding a fusion protein in which a protective peptide is bound to the physiologically active peptide via an aspartic acid-proline sequence, and collecting the fusion protein from the resulting culture A method for producing a physiologically active peptide having no aspartic acid-proline sequence, which comprises cleaving the aspartic acid-proline bond of the fusion protein with an acid. [Effects] According to the method of the present invention, a low molecular weight physiologically active peptide represented by hBNP can be easily and efficiently produced using recombinant DNA technology. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6124430-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8609621-B2 |
| priorityDate |
1991-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |